Thursday, April 22, 2021
Home Life Style Health & Fitness A Potential New Target For Anti-Covid-19 Therapies

A Potential New Target For Anti-Covid-19 Therapies

The research team also showed that the coronavirus enzyme PLpro physically interacts with the receptor MDA5 and inhibits the ISGylation process

A team of researchers has identified a potential new target for anti-Covid-19 therapies.
The findings, published in Nature Microbiology, indicated that a coronavirus enzyme called PLpro (papain-like protease) blocks the body’s immune response to the infection.

“Our findings offer insights into a never-before characterized mechanism of immune activation and how PLpro disrupts this response, enabling SARS-CoV-2 to freely replicate and wreak havoc throughout the host,” said researcher Michaela Gack from the University of Chicago in the US.

Follow NewsGram on LinkedIn to know what’s happening around the world.

“We discovered that inhibiting PLpro may help rescue the early immune response that is key to limiting viral replication and spread,” Gack added. One of the body’s frontline immune defenses is a class of receptor proteins, including one called MDA5, that identify invaders by foreign patterns in their genetic material. When the receptors recognize a foreign pattern, they become activated and kick-start the immune system into the antiviral mode.

ALSO READ: Study: Covid19 Survivors Likely To Be Affected By Cognitive Complications

This is done in part by increasing the downstream expression of proteins encoded by interferon-stimulated genes (ISGs), the researchers said. In this study, the team identified a novel mechanism that leads to MDA5 activation during virus infection. They found that ISG15 must physically bind to specific regions in the MDA5 receptor — a process termed ISGylation — in order for MDA5 to effectively activate and unleash antiviral actors against invaders.

They showed that ISGylation helps to promote the formation of larger MDA5 protein complexes, which ultimately results in a more robust immune response against a range of viruses. The research team also showed that the coronavirus enzyme PLpro physically interacts with the receptor MDA5 and inhibits the ISGylation process. The researchers said that more research is necessary, but the findings suggest that therapeutics that inhibit the enzyme may help treat Covid-19. (IANS/SP)



Most Popular

All In The Mind: The State Of Mental Health In Corporate India

A study highlighting the role of the workplace in causing, furthering, and perpetuating mental illness, launched by Gi Group India, a leading human capital...

Instagram’s New Feature To Protect People From Abusive DMs

Facebook-owned Instagram on Wednesday announced a new feature to protect people from seeing abusive direct messages (DMs), as well as the ability to prevent...

Spiritual Power To Guard: Devotees Of Lord Ram Spread Message Of Covid19 Norms

In the wake of Bengaluru witnessing an unprecedented surge in Covid cases since the last month, devotees of Lord Ram wore costumes of Ram,...

Know What Lies Behind Tehreek-e-Labaik Pakistan’s Challenge To The State?

Pakistan's government has been put under a severe challenge and test by an Islamist party, which has wreaked havoc in the country this week...

Religious Hardliners Bring Pakistan Govt To A Standstill

The current ruling government of Pakistan, led by Prime Minister Imran Khan, may have come with a vision of progress and open-mindedness to create...

Football And Its Evolution

By- Khushi Bisht Football, also known as soccer, has a long and illustrious history. According to a global study conducted by FIFA, over 250 million...

Nikola Tesla: A Man Ahead Of His Time

BY- JAYA CHOUDHARY When discussing the greatest inventors of all time, Nikola Tesla is sometimes overlooked in history lessons at school. We often hear names...

The Best Documentaries You Can Watch On The Internet Today

By Nauman Abrar As children, most of us disliked documentaries because they were long, boring, very close to reality, and based on the truth. That...

Recent Comments